TM editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.
Company: YiChang HEC ChangJiang Pharmaceutical Limited
Bloomberg ticker: 1558 HK
Market cap: US$2,125m
Background: YiChang HEC ChangJiang Pharmaceutical Company Limited develops, manufactures, and sells pharmaceutical products in anti-virus, endocrine and metabolic diseases, and cardiovascular diseases. The majority of the company’s revenue is derived from anti-influenza virus products sold under the brand Kewei.
World Class Benchmarking of YiChang HEC ChangJiang Pharmaceutical
(Click on image to enlarge)
- Profitable Growth rank of 1 was same compared to the prior period’s 1st rank
- This is World Class performance compared to 390 medium Health Care companies worldwide
- Profitability rank of 1 was better than its Growth rank of 2
- Profitability rank of 1 was the same compared to the prior period’s 1st rank
- This is World Class performance compared to peers
- Growth rank of 2 was up compared to the prior period’s 3rd rank
- This is World Class performance compared to peers
Comments
Log in or sign up to join the conversation.